
US FDA advisers recommend against Otsuka’s PTSD combination treatment
Audio By Carbonatix By Mariam Sunny and Siddhi Mahatole (Reuters) -The U.S. Food and Drug Administration’s panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma’s antipsychotic drug in combination with Viatris’ antidepressant …